Multiple Myeloma

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Research Summaries

treatment
doctor with patient
treatment
Multiple Myeloma Management in Primary Care
11/17/2022
Optimal management of multiple myeloma is evolving with the introduction of new and emerging therapeutic options. Ajay K. Nooka, MD, MPH, discusses these treatment options and updates to the standards of...
11/17/2022
Immunology
virus immune cells
Immunology
CD56 Has a Key Role in Regulating Multiple Myeloma Cell Growth, Treatment Responses
12/31/2021
The researchers analyzed 569 patients with multiple myeloma, stratified patients on the basis of their percentage of CD56-expressing clonal MM cells, and then evaluated patient outcomes based on this...
12/31/2021
Viral Infections
COVID facemask
Viral Infections
COVID-19 Infection Increases Antibody Response Against SARS-CoV-2 in Patients With Multiple Myeloma
12/14/2021
To determine whether patients with multiple myeloma have a suboptimal antibody response to vaccination against COVID-19, researchers evaluated 35 patients with multiple myeloma who were diagnosed with...
12/14/2021
Tumors
cancer cells
Tumors
For Multiple Myeloma, Add-on Minimally Invasive Scan Predicts Prognosis
12/14/2021
To examine the prognostic value of flow cytometry plus PET/CT scanning for detecting minimal residual disease in patients with multiple myeloma, researchers conducted an observational cohort study of 94...
12/14/2021
Patient Outcomes
stem cells
Patient Outcomes
Study Identified Factors Related to Multiple Myeloma Disease Outcomes
12/14/2021
For their study, the researchers aimed to clarify the mechanisms behind racial and ethnic disparities in multiple myeloma disease outcomes by investigating the demographic, clinical, and molecular features...
12/14/2021
Multiple Myeloma
blood cells circulating
Multiple Myeloma
Results From MAIA Study May Open New Doors for Patients With Multiple Myeloma
12/09/2021
The MAIA study was a phase 3 trial comparing lenalidomide and dexamethasone alone with daratumumab as an add-on therapy to lenalidomide and dexamethasone in patients with transplant-ineligible newly...
12/09/2021
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma: Screening High-Risk Patients Lowers Risk of Death
03/28/2018
It is currently unclear how to best screen populations at risk for multiple myeloma and evaluate the potential effectiveness of early interventions. Using a computational model, researchers investigated...
03/28/2018
Multiple Myeloma
Multiple Myeloma
BMI, Age Impact the Risk for Multiple Myeloma
03/20/2018
An analysis of patient data from the Nurses’ Health Study, Health Professional Follow-Up Study and Women’s Health Study is leading researchers to make associations between age and modifiable risk factors...
03/20/2018
Multiple Myeloma
Multiple Myeloma
FDA Approves New Immunotherapy for Multiple Myeloma Patients
06/19/2017
The US Food and Drug Administration has approved an immunotherapy with the first CD38-directed antibody to be approved in any country.
06/19/2017
Conference Coverage
Drs Mikhael and Watson
Conference Coverage
Video Recap—Multiple Myeloma Across the Care Continuum
05/13/2016
Brittany Watson, MD, MPH; Joseph Mikhael, MD, MEd, FRCPC
In this video, Brittany Watson, MD, MPH, FAAFP, DABOM and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of primary care in the early recognition and diagnosis of multiple myeloma, including the...
05/13/2016